Ghoshal Kaushik's Form 4 filing
Resmed Inc (RMD) · filed Mar 11, 2025
- Accession no.
- 0001127602-25-009051
- Filed
- Mar 11, 2025
- Trade date
- Mar 10, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $2.33M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ghoshal KaushikCIK 0001881922 | Officer (Chief Commercial Officer, SaaS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | ResMed Common Stock | MOption exerciseAcquired | +169 | $146.34 | +$24,731.46 | 9,894 | Direct | |
| Mar 10, 2025 | ResMed Common Stock | MOption exerciseAcquired | +105 | $211.76 | +$22,234.8 | 9,999 | Direct | |
| Mar 10, 2025 | ResMed Common Stock | MOption exerciseAcquired | +3,589 | $146.34 | +$525,214.26 | 13,588 | Direct | |
| Mar 10, 2025 | ResMed Common Stock | MOption exerciseAcquired | +5,882 | $211.76 | +$1,245,572.32 | 19,470 | Direct | |
| Mar 10, 2025 | ResMed Common Stock | SSaleDisposed | −9,745 | $239.31F2 | −$2,332,075.95 | 9,725 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | ResMed Common Stock | MOption exerciseDisposed | −169 | $0.00 | $0 | 0 | Direct | |
| Mar 10, 2025 | ResMed Common Stock | MOption exerciseDisposed | −105 | $0.00 | $0 | 0 | Direct | |
| Mar 10, 2025 | ResMed Common Stock | MOption exerciseDisposed | −5,882 | $0.00 | $0 | 0 | Direct | |
| Mar 10, 2025 | ResMed Common Stock | MOption exerciseDisposed | −3,589 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $236.62 - $242.73. The price reported above reflects the weighted average sale price.
Referenced by the price of 1 transaction in Table I.